Skip to main content

Linux Laboratories

Type

investor

Founded

2007

Funding Rounds

0

Portfolio companies

0

About Linux Laboratories

Linux Laboratories is a multinational pharmaceutical company focused on branded and specialty generic medicines, with particular strength in neuropsychiatry and central nervous system therapies. Its portfolio also spans critical care, dermatology, nutraceuticals, and cardio-diabetic treatments. The company develops and acquires pharmaceutical brands, manufactures products at WHO-GMP-certified facilities, provides contract manufacturing services, and exports to international markets, emphasizing accessible, affordable medicines for healthcare professionals and patients.

Linux Laboratories funding captured (1)

Deal typeStageDateAmountInvestors
HybridUnspecifiedOct 3, 2026$70.0m
TataTata +1